Peroxisomes compensate hepatic lipid overflow in mice with fatty liver

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 7, 2015, Pages 965-976

  Knebel, Birgit ^a   Hartwig, Sonja ^a   Haas, Jutta ^b   Lehr, Stefan ^a   Goeddeke, Simon ^a   Susanto, Franciscus ^a   Bohne, Lothar ^a   Jacob, Sylvia ^a   Koellmer, Cornelia ^a   Nitzgen, Ulrike ^a   Müller Wieland, Dirk ^b   Kotzka, Jorg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

Cytokines; Dyslipidemia; Fatty acids; Gene expression; Mitochondrial and peroxisomal protein profiles; NAFLD

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CELL ADHESION MOLECULE; COLONY STIMULATING FACTOR 1; CXCL1 CHEMOKINE; GLUTAMATE DEHYDROGENASE; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CATABOLISM; CELL FRACTIONATION; CONTROLLED STUDY; ENERGY BALANCE; ENZYME ACTIVITY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FOOD INTAKE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOTYPE; HYPERPHAGIA; LIPID COMPOSITION; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; MALE; MITOCHONDRION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PEROXISOME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WEIGHT GAIN;

MUS;

EID: 84963958773     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2015.03.003     Document Type: Article

References (43)

1. N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, and K. Cusi et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 2012 1592 1609
2. D.E. Kleiner, and E.M. Brunt Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research Semin. Liver Dis. 32 2013 3 13
3. S.H. Koo Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis Clin. Mol. Hepatol. 19 2013 210 215
4. K.F. Petersen, S. Dufour, D. Befroy, R. Garcia, and G.I. Shulman Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N. Engl. J. Med. 350 2004 664 671
5. I. Zeb, R. Katz, K. Nasir, J. Ding, P. Rezaeian, and M.J. Budoff Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis J. Cardiovasc. Comput. Tomogr. 7 2013 311 318
6. S. Hartwig, B. Knebel, S. Goeddeke, C. Koellmer, S. Jacob, and U. Nitzgen et al. So close and yet so far: mitochondria and peroxisomes are one but with specific talents Arch. Physiol. Biochem. 119 2013 126 135
7. K.P. Hummel, M.M. Dickie, and D.L. Coleman Diabetes, a new mutation in the mouse Science 153 1966 1127 1128
8. B. Wang, P.C. Chandrasekera, and J.J. Pippin Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes Curr. Diabetes Rev. 10 2014 131 145
9. S. Horvat, and L. Bunger Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay for the mouse leptin receptor (Lepr(db)) mutation Lab. Anim. 33 1999 380 384
10. B. Knebel, J. Haas, S. Hartwig, S. Jacob, C. Köllmer, and U. Nitzgen et al. Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass PLoSOne 7 2012 e31812
11. J. Kotzka, B. Knebel, J. Haas, L. Kremer, S. Jacob, and S. Hartwig et al. Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity PLoSOne 7 2012 e32609
12. J. Kotzka, B. Knebel, H. Avci, S. Jacob, U. Nitzgen, and F. Jockenhovel Phosphorylation of sterol regulatory element-binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes Atherosclerosis 213 2010 156 165
13. B. Knebel, J. Kotzka, S. Lehr, S. Hartwig, H. Avci, and S. Jacob et al. A mutation in the c-fos gene associated with congenital generalized lipodystrophy Orphanet. J. Rare Dis. 8 2013 119
14. J. Chen, E.E. Bardes, B.J. Aronow, and A.G. Jegga ToppGene Suite for gene list enrichment analysis and candidate gene prioritization Nucleic Acids Res. 37 2009 W305 W311
15. J. Wang, D. Duncan, Z. Shi, and B. Zhang WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 Nucleic Acids Res. 41 2013 W77 W83
16. D.W. Huang, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 4 2009 44 57
17. M. Morelli M. Gaggini, E. Buzzigoli, R.A. DeFronzo, E. Bugianesi, and A. Gastaldelli Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Nutrients 5 2013 1544 1560
18. R.H. Unger, G.O. Clark, P.E. Scherer, and L. Orci Lipid homeostasis, lipotoxicity and the metabolic syndrome Biochim. Biophys. Acta 1801 2010 209 214
19. E.H. Leiter, D.L. Coleman, and K.P. Hummel The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. III. Effect of H-2 haplotype and sex Diabetes 30 1981 1029 1034
20. J.M. Schattenberg, and P.R. Galle Animal models of non-alcoholic steatohepatitis: of mice and man Dig. Dis. 28 2010 247 254
21. M.F. Gregor, and G.S. Hotamisligil Inflammatory mechanisms in obesity Annu. Rev. Immunol. 29 2011 415 445
22. A. Guiu-Jurado E. Berlanga, J.A. Porras, and T. Auguet Molecular pathways in non-alcoholic fatty liver disease Clin. Exp. Gastroenterol. 7 2014 221 239
23. L. Herrero, H. Shapiro, A. Nayer, J. Lee, and S.E. Shoelson Inflammation and adipose tissue macrophages in lipodystrophic mice Proc. Natl. Acad. Sci. U. S. A. 107 2010 240 245
24. W. Liang, J.H. Lindeman, A.L. Menke, D.P. Koonen, M. Morrison, and L.M. Havekes et al. Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation Lab. Invest. 94 2014 491 502
25. H. Bjermo, and U. Riserus Role of hepatic desaturases in obesity-related metabolic disorders Curr. Opin Clin. Nutr Metab. Care 13 2010 703 708
26. X. Wang, Y. Cao, Y. Fu, G. Guo, and X. Zhang Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease Lipids Health Dis. 10 2011 234
27. H. Bugger, D. Chen, C. Riehle, J. Soto, H.A. Theobald, and X.X. Hu et al. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice Diabetes 58 2009 1986 1997
28. J. Ciapaite, N.M. van den Broek, H. Te Brinke, K. Nicolay, J.A. Jeneson, and S.M. Houten et al. Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats Biochim. Biophys. Acta 1811 2011 441 451
29. I.G. Shabalina, M. Vrbacký, A. Pecinová, A.V. Kalinovich, Z. Drahota, and J. Houštěk et al. ROS production in brown adipose tissue mitochondria: the question of UCP1-dependence Biochim. Biophys. Acta 1837 2014 2017 2030
30. G. Serviddio, F. Bellanti, R. Tamborra, T. Rollo, A.D. Romano, and A.M. Giudetti et al. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model Eur. J. Clin. Invest. 38 2008 245 252
31. Y. Jiang, H. Zhang, L.Y. Dong, D. Wang, and W. An Increased hepatic UCP2 expression in rats with nonalcoholic steatohepatitis is associated with upregulation of Sp1 binding to its motif within the proximal promoter region J. Cell. Biochem. 105 2008 277 289
32. M. Schrader, S. Grille, H.D. Fahimi, and M. Islinger Peroxisome interactions and cross-talk with other subcellular compartments in animal cells Subcell. Biochem. 69 2013 1 22
33. V.D. Antonenkov et al. Peroxisomes are oxidative organelles Antioxid. Redox Signal. 13 2010 525 537
34. D.B. Jump, S. Tripathy, and C.M. Depner Fatty acid-regulated transcription factors in the liver Annu. Rev. Nutr. 33 2013 249 269
35. T. Vallim, and A.M. Salter Regulation of hepatic gene expression by saturated fatty acids Prostaglandins Leukot. Essent. Fat. Acids 82 2010 211 218
36. A. Bagattin, L. Hugendubler, and E. Mueller Transcriptional coactivator PGC-1alpha promotes peroxisomal remodeling and biogenesis Proc. Natl. Acad. Sci. U. S. A. 107 2010 20376 20381
37. R.C. Scarpulla, R.B. Vega, and D.P. Kelly Transcriptional integration of mitochondrial biogenesis Trends Endocrinol. Metab. 23 2012 459 466
38. R. Ventura-Clapier, A. Garnier, and V. Veksler Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha Cardiovasc. Res. 79 2008 208 217
39. C.J. Pirola, T.F. Gianotti, A.L. Burgueño, M. Rey-Funes, C.F. Loidl, and P. Mallardi et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease Gut 62 2013 1356 1363
40. M. Del Ben, L. Polimeni, F. Baratta, D. Pastori, L. Loffredo, and F. Angelico Modern approach to the clinical management of non-alcoholic fatty liver disease World J. Gastroenterol. 20 2014 8341 8350
41. D. Shyangdan, C. Clar, N. Ghouri, R. Henderson, T. Gurung, and D. Preiss et al. Insulin sensitizers in the treatment of non-alcoholic fatty liver disease: a systematic review Health Technol. Assess. 15 2011 1 110
42. H. Weng, X. Ji, Y. Naito, K. Endo, X. Ma, and R. Takahashi et al. Pex11alpha deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice Am. J. Physiol. Endocrinol. Metab. 304 2013 E187 E196
43. S.D. Kohlwein, M. Veenhuis, and I.J. van der Klei Lipid droplets and peroxisomes: key players in cellular lipid homeostasis or a matter of fat - store 'em up or burn 'em down Genetics 193 2013 1 50